Literature DB >> 17505494

"Personalized medicine: elusive dream or imminent reality?": A commentary.

A Roses1.   

Abstract

I was invited to comment on the article in this issue by Larry Lesko, "Personalized Medicine: Elusive Dream or Imminent Reality?",(1) especially with respect to three questions. There are several possible approaches to discussing these questions. One is to simply answer the question as directly and succinctly as possible; another is to expand on the questions. For the purpose of this Commentary, I try to do both.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17505494     DOI: 10.1038/sj.clpt.6100227

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  Clinician adoption of genetic testing for drug metabolizing enzymes: is patient safety the low-hanging fruit of personalized medicine?

Authors:  Harry Enchin
Journal:  AMIA Annu Symp Proc       Date:  2009-11-14

Review 2.  From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.

Authors:  Daniel W Nebert; Ge Zhang; Elliot S Vesell
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.